Big Pharma joins £200M UK Biobank sequencing project; Monopar sets terms for $40M IPO
→ The UK Biobank is kicking off an ambitious £200 million project to undertake whole-genome sequencing of 450,000 participants, probing the role that genetics …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.